AKT1 and melanoma: As shown in Figure 7A and 7B, treatment of MK-2206, an AKT inhibitor, alone or U0126, a MEK inhibitor, alone for 1 h markedly increased STAT3 phosphorylation at tyr705 site in human melanoma A375S and A2058 cells.